The medical device contract manufacturing market size has grown rapidly in recent years. It will grow from $114.66 billion in 2025 to $131.36 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to rising medical device innovation cycles, increasing regulatory complexity in medtech manufacturing, growing cost pressures on OEMs, expansion of global medtech startups, demand for specialized manufacturing expertise.
The medical device contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $228.23 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing adoption of advanced manufacturing technologies, rising demand for rapid device commercialization, expansion of personalized and minimally invasive devices, growing focus on supply chain resilience, increasing partnerships between OEMs and CMOs. Major trends in the forecast period include increasing outsourcing of complex device manufacturing, rising demand for end-to-end contract manufacturing services, growing focus on regulatory-compliant production capabilities, expansion of scalable manufacturing infrastructure, enhanced emphasis on quality and risk management.
The increasing prevalence of chronic disorders is anticipated to drive the expansion of the medical device contract manufacturing market in the coming years. Chronic disorders are long-term health conditions, including cardiovascular diseases, diabetes, and respiratory illnesses, that persist over extended periods and typically require ongoing medical care, monitoring, and intervention. The growing burden of these conditions is largely attributed to aging populations and lifestyle-related factors, as longer life expectancy combined with sedentary habits, unhealthy diets, and reduced physical activity contributes to higher incidence rates of chronic diseases. This rising prevalence fuels demand for a wide range of specialized medical devices, such as monitoring systems, implantable products, and diagnostic equipment, which are essential for effective long-term disease management. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a United States-based organization, 76.4 percent of U.S. adults, representing around 194 million people, reported having at least one chronic condition, while 51.4 percent, or approximately 130 million individuals, reported living with two or more chronic conditions. Consequently, the growing prevalence of chronic disorders is supporting the growth of the medical device contract manufacturing market.
Leading companies operating in the medical device contract manufacturing sector are increasingly emphasizing innovative initiatives such as integrated new product introduction (NPI) platforms to accelerate device development and enable smooth transitions to large-scale production. Integrated NPI platforms are comprehensive, end-to-end systems that bring together design, prototyping, testing, and manufacturing readiness within a unified workflow, allowing medical device companies to shorten development timelines, enhance quality assurance, reduce production risks, and speed up the shift from concept to commercialization. For example, in March 2025, Flex Ltd., a United States-based manufacturing company, announced the launch of its new NPI Center near Boston, a prominent global hub for medical technology innovation. The facility is designed to strengthen end-to-end product realization and includes an 8,000 square foot development laboratory capable of supporting concurrent prototype and preclinical builds, along with a 2,000 square foot validation and quality testing area, and is planned to achieve ISO 13485 certification by the second quarter of 2025. Supporting applications across surgical robotics, medical devices, imaging systems, and laboratory diagnostics, the center enables original equipment manufacturers to lower development risks, reduce time-to-market, and benefit from an integrated manufacturing ecosystem.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Binding Site Group for around $2.8 billion. This acquisition enhances Thermo Fisher's specialty diagnostics portfolio by incorporating innovative diagnostics and monitoring solutions for multiple myeloma. This expansion facilitates earlier diagnosis and enables more informed treatment decisions, ultimately improving patient outcomes. Thermo Fisher is committed to advancing this field further for the benefit of patients. Binding Site Group is a UK-based company that specializes in medical device contract manufacturing.
Major companies operating in the medical device contract manufacturing market are Phillips-Medisize Corporation, Integer Holdings Corporation, Flex Ltd, Sanmina Corporation, Plexus Corporation, Benchmark Electronics Inc, Celestica International LP, Jabil Inc, Kimball Electronics Inc, Nortech Systems Inc, Gerresheimer AG, Catalent Inc, Nemera Development S.A., Consort Medical plc, Invetech, SteriPack Group Ltd, Forefront Medical Technologies Pte Ltd, Nipro Corporation, TE Connectivity Ltd, West Pharmaceutical Services Inc.
North America will be the largest region in the medical device contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical device contract manufacturing market by increasing costs of imported raw materials, electronic components, precision parts, and specialized manufacturing equipment used across diagnostics, cardiovascular, and drug delivery devices. North America and Europe are most affected due to cross-border sourcing of components, while Asia-Pacific faces cost pressure on export-oriented manufacturing hubs. These tariffs are increasing production costs and affecting pricing strategies for OEMs. However, they are also encouraging regional manufacturing diversification, local sourcing initiatives, and long-term investments in domestic contract manufacturing capabilities.
The medical device contract manufacturing market research report is one of a series of new reports that provides medical device contract manufacturing market statistics, including medical device contract manufacturing industry global market size, regional shares, competitors with a medical device contract manufacturing market share, detailed medical device contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract manufacturing industry. This medical device contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical device contract manufacturing involves a process in which a Medtech company, which owns the intellectual property, outsources the manufacturing of medical devices to another specialized manufacturing firm. This outsourcing arrangement is often chosen for benefits such as cost optimization, device upgrades, regulatory guidance, or expansion purposes.
The main types of medical devices in contract manufacturing include in vitro diagnostic (IVD) devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, ophthalmology devices, orthopedic devices, dental devices, and other devices. In vitro diagnostic (IVD) devices are medical devices used alone or in combination with other diagnostic products for in vitro use, including apparatus, equipment, or systems. The services provided by medical device contract manufacturing include device development and manufacturing services, quality management services, and assembly services. The applications of contract manufacturing services span various medical fields, including laparoscopy, pulmonary, urology, gynecology, and other applications.
The medical device contract manufacturing market includes revenues earned by entities by quality management system, ISO certified clean rooms, sterilization validation and recurring services, package design and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical device contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $228.23 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing adoption of advanced manufacturing technologies, rising demand for rapid device commercialization, expansion of personalized and minimally invasive devices, growing focus on supply chain resilience, increasing partnerships between OEMs and CMOs. Major trends in the forecast period include increasing outsourcing of complex device manufacturing, rising demand for end-to-end contract manufacturing services, growing focus on regulatory-compliant production capabilities, expansion of scalable manufacturing infrastructure, enhanced emphasis on quality and risk management.
The increasing prevalence of chronic disorders is anticipated to drive the expansion of the medical device contract manufacturing market in the coming years. Chronic disorders are long-term health conditions, including cardiovascular diseases, diabetes, and respiratory illnesses, that persist over extended periods and typically require ongoing medical care, monitoring, and intervention. The growing burden of these conditions is largely attributed to aging populations and lifestyle-related factors, as longer life expectancy combined with sedentary habits, unhealthy diets, and reduced physical activity contributes to higher incidence rates of chronic diseases. This rising prevalence fuels demand for a wide range of specialized medical devices, such as monitoring systems, implantable products, and diagnostic equipment, which are essential for effective long-term disease management. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a United States-based organization, 76.4 percent of U.S. adults, representing around 194 million people, reported having at least one chronic condition, while 51.4 percent, or approximately 130 million individuals, reported living with two or more chronic conditions. Consequently, the growing prevalence of chronic disorders is supporting the growth of the medical device contract manufacturing market.
Leading companies operating in the medical device contract manufacturing sector are increasingly emphasizing innovative initiatives such as integrated new product introduction (NPI) platforms to accelerate device development and enable smooth transitions to large-scale production. Integrated NPI platforms are comprehensive, end-to-end systems that bring together design, prototyping, testing, and manufacturing readiness within a unified workflow, allowing medical device companies to shorten development timelines, enhance quality assurance, reduce production risks, and speed up the shift from concept to commercialization. For example, in March 2025, Flex Ltd., a United States-based manufacturing company, announced the launch of its new NPI Center near Boston, a prominent global hub for medical technology innovation. The facility is designed to strengthen end-to-end product realization and includes an 8,000 square foot development laboratory capable of supporting concurrent prototype and preclinical builds, along with a 2,000 square foot validation and quality testing area, and is planned to achieve ISO 13485 certification by the second quarter of 2025. Supporting applications across surgical robotics, medical devices, imaging systems, and laboratory diagnostics, the center enables original equipment manufacturers to lower development risks, reduce time-to-market, and benefit from an integrated manufacturing ecosystem.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Binding Site Group for around $2.8 billion. This acquisition enhances Thermo Fisher's specialty diagnostics portfolio by incorporating innovative diagnostics and monitoring solutions for multiple myeloma. This expansion facilitates earlier diagnosis and enables more informed treatment decisions, ultimately improving patient outcomes. Thermo Fisher is committed to advancing this field further for the benefit of patients. Binding Site Group is a UK-based company that specializes in medical device contract manufacturing.
Major companies operating in the medical device contract manufacturing market are Phillips-Medisize Corporation, Integer Holdings Corporation, Flex Ltd, Sanmina Corporation, Plexus Corporation, Benchmark Electronics Inc, Celestica International LP, Jabil Inc, Kimball Electronics Inc, Nortech Systems Inc, Gerresheimer AG, Catalent Inc, Nemera Development S.A., Consort Medical plc, Invetech, SteriPack Group Ltd, Forefront Medical Technologies Pte Ltd, Nipro Corporation, TE Connectivity Ltd, West Pharmaceutical Services Inc.
North America will be the largest region in the medical device contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical device contract manufacturing market by increasing costs of imported raw materials, electronic components, precision parts, and specialized manufacturing equipment used across diagnostics, cardiovascular, and drug delivery devices. North America and Europe are most affected due to cross-border sourcing of components, while Asia-Pacific faces cost pressure on export-oriented manufacturing hubs. These tariffs are increasing production costs and affecting pricing strategies for OEMs. However, they are also encouraging regional manufacturing diversification, local sourcing initiatives, and long-term investments in domestic contract manufacturing capabilities.
The medical device contract manufacturing market research report is one of a series of new reports that provides medical device contract manufacturing market statistics, including medical device contract manufacturing industry global market size, regional shares, competitors with a medical device contract manufacturing market share, detailed medical device contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract manufacturing industry. This medical device contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical device contract manufacturing involves a process in which a Medtech company, which owns the intellectual property, outsources the manufacturing of medical devices to another specialized manufacturing firm. This outsourcing arrangement is often chosen for benefits such as cost optimization, device upgrades, regulatory guidance, or expansion purposes.
The main types of medical devices in contract manufacturing include in vitro diagnostic (IVD) devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, ophthalmology devices, orthopedic devices, dental devices, and other devices. In vitro diagnostic (IVD) devices are medical devices used alone or in combination with other diagnostic products for in vitro use, including apparatus, equipment, or systems. The services provided by medical device contract manufacturing include device development and manufacturing services, quality management services, and assembly services. The applications of contract manufacturing services span various medical fields, including laparoscopy, pulmonary, urology, gynecology, and other applications.
The medical device contract manufacturing market includes revenues earned by entities by quality management system, ISO certified clean rooms, sterilization validation and recurring services, package design and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical Device Contract Manufacturing Market Characteristics
3. Medical Device Contract Manufacturing Market Supply Chain Analysis
4. Global Medical Device Contract Manufacturing Market Trends and Strategies
5. Medical Device Contract Manufacturing Market Analysis of End Use Industries
7. Global Medical Device Contract Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical Device Contract Manufacturing Total Addressable Market (TAM) Analysis for the Market
9. Medical Device Contract Manufacturing Market Segmentation
10. Medical Device Contract Manufacturing Market Regional and Country Analysis
11. Asia-Pacific Medical Device Contract Manufacturing Market
12. China Medical Device Contract Manufacturing Market
13. India Medical Device Contract Manufacturing Market
14. Japan Medical Device Contract Manufacturing Market
15. Australia Medical Device Contract Manufacturing Market
16. Indonesia Medical Device Contract Manufacturing Market
17. South Korea Medical Device Contract Manufacturing Market
18. Taiwan Medical Device Contract Manufacturing Market
19. South East Asia Medical Device Contract Manufacturing Market
20. Western Europe Medical Device Contract Manufacturing Market
21. UK Medical Device Contract Manufacturing Market
22. Germany Medical Device Contract Manufacturing Market
23. France Medical Device Contract Manufacturing Market
24. Italy Medical Device Contract Manufacturing Market
25. Spain Medical Device Contract Manufacturing Market
26. Eastern Europe Medical Device Contract Manufacturing Market
27. Russia Medical Device Contract Manufacturing Market
28. North America Medical Device Contract Manufacturing Market
29. USA Medical Device Contract Manufacturing Market
30. Canada Medical Device Contract Manufacturing Market
31. South America Medical Device Contract Manufacturing Market
32. Brazil Medical Device Contract Manufacturing Market
33. Middle East Medical Device Contract Manufacturing Market
34. Africa Medical Device Contract Manufacturing Market
36. Medical Device Contract Manufacturing Market Competitive Landscape and Company Profiles
37. Medical Device Contract Manufacturing Market Other Major and Innovative Companies
40. Medical Device Contract Manufacturing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical Device Contract Manufacturing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical device contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical device contract manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device contract manufacturing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device: IVD Devices; Diagnostic Imaging Devices; Cardiovascular Devices; Drug Delivery Devices; Endoscopy Devices; Ophthalmology Devices; Orthopedic Devices; Dental Devices; Other Devices2) By Service: Device Development and Manufacturing Service; Quality Management Service; Assembly Service
3) By Application: Design And Prototyping; Component Manufacturing; Device Assembly And Integration; Packaging And Sterilization; Quality Assurance And Testing; Regulatory And Compliance Support; Lifecycle Management And Scale-Up Manufacturing
Subsegments:
1) By In Vitro Diagnostics (IVD) Devices: Reagents; Test Kits; Assays2) By Diagnostic Imaging Devices: X-ray Machines; MRI Machines; Ultrasound Equipment
3) By Cardiovascular Devices: Stents; Catheters; Pacemakers
4) By Drug Delivery Devices: Infusion Pumps; Nebulizers; Auto-Injectors
5) By Endoscopy Devices: Flexible Endoscopes; Rigid Endoscopes; Accessories
6) By Ophthalmology Devices: Intraocular Lenses (IOLs); Diagnostic Equipment; Surgical Instruments
7) By Orthopedic Devices: Implants; Surgical Tools; Prosthetics
8) By Dental Devices: Dental Implants; Orthodontic Devices; Dental Chairs
9) By Other Devices: Surgical Instruments; Monitoring Devices; Wearable Health Tech
Companies Mentioned: Phillips-Medisize Corporation; Integer Holdings Corporation; Flex Ltd; Sanmina Corporation; Plexus Corporation; Benchmark Electronics Inc; Celestica International LP; Jabil Inc; Kimball Electronics Inc; Nortech Systems Inc; Gerresheimer AG; Catalent Inc; Nemera Development S.A.; Consort Medical plc; Invetech; SteriPack Group Ltd; Forefront Medical Technologies Pte Ltd; Nipro Corporation; TE Connectivity Ltd; West Pharmaceutical Services Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Device Contract Manufacturing market report include:- Phillips-Medisize Corporation
- Integer Holdings Corporation
- Flex Ltd
- Sanmina Corporation
- Plexus Corporation
- Benchmark Electronics Inc
- Celestica International LP
- Jabil Inc
- Kimball Electronics Inc
- Nortech Systems Inc
- Gerresheimer AG
- Catalent Inc
- Nemera Development S.A.
- Consort Medical plc
- Invetech
- SteriPack Group Ltd
- Forefront Medical Technologies Pte Ltd
- Nipro Corporation
- TE Connectivity Ltd
- West Pharmaceutical Services Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 131.36 Billion |
| Forecasted Market Value ( USD | $ 228.23 Billion |
| Compound Annual Growth Rate | 14.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
